Guardian Pharmacy Services, Inc.

$37.63+3.72%(+$1.35)
TickerSpark Score
85/100
Strong
73
Valuation
75
Profitability
95
Growth
84
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GRDN research report →

52-Week Range83% of range
Low $19.17
Current $37.63
High $41.36

Companyguardianpharmacy.com

Guardian Pharmacy Services, Inc. , a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

CEO
Fred Burke
IPO
2016
Employees
3,400
HQ
Atlanta, GA, US

Price Chart

+42.00% · this period
$40.65$30.16$19.67May 20Nov 18May 20

Valuation

Market Cap
$2.38B
P/E
44.90
P/S
1.64
P/B
10.79
EV/EBITDA
23.19
Div Yield
0.00%

Profitability

Gross Margin
20.93%
Op Margin
5.31%
Net Margin
3.64%
ROE
27.21%
ROIC
19.15%

Growth & Income

Revenue
$1.45B · 17.93%
Net Income
$49.22M · 156.39%
EPS
$0.79 · 144.63%
Op Income
$88.91M
FCF YoY
94.05%

Performance & Tape

52W High
$41.36
52W Low
$19.17
50D MA
$36.55
200D MA
$30.61
Beta
0.09
Avg Volume
461.26K

Get TickerSpark's AI analysis on GRDN

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
May 5, 26COSLER STEVEN Dother4,028
May 5, 26LEWIS RANDALL Jother4,028
May 5, 26Patchett Mary Sueother4,028
Apr 1, 26Eakins Richardother0
Apr 1, 26Eakins Richardother36,052
Apr 1, 26Eakins Richardother25,000
Apr 1, 26Mudd William Franklinother0
Apr 1, 26Mudd William Franklinother25,000
Apr 1, 26Mudd William Franklinother38,282
Apr 1, 26Towns Douglasother0

Our GRDN Coverage

We haven't published any research on GRDN yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate GRDN Report →

Similar Companies